SEARCH
Kotak Institutional Equities upbeat on Cipla
CNBC-TV18
2019-02-19
Views
4
Description
Share / Embed
Download This Video
Report
Currently, they prefer Cipla and Torrent pharma which have a strong domestic franchise underpinning the valuation and providing downside support. Cipla remains their top pick, said Chirag Talati, Associate Director, Kotak Institutional Equities
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x72nlor" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
00:40
TLTROs To Work Once Credit Growth Picks Up: Kotak Institutional Equities' Rakshit
10:46
Kotak Institutional Equities- Expect RBI to cut rate by 25 bps every quarter
11:41
Kotak Institutional Equities on outlook for market
10:28
Govt must take policy action - Kotak Institutional Equities
11:10
Sanjeev Prasad of Kotak Institutional Equities on market & specific sectors
12:26
Sanjeev Prasad Of Kotak Institutional Equities On Indian Markets & More
05:17
Hitesh Goel of Kotak Institutional Equities on auto sector
09:42
ET Now Exclusive: Sandeep Bhatia, Executive Director & Head of Sales, Kotak Institutional Equities
02:52
If I were FM | Associate Director, Kotak Institutional Equities
07:29
Sanjeev Prasad of Kotak Institutional Equities on India & emerging markets
09:51
Institutional allocations to US equities hit an 18-year low. So how are equities up?
00:18
Institutional Equities and the Broker Dealer An Introduction
